发布求助
文献互助 智能选刊 最新文献

Case Reports in Hematology最新文献

筛选
英文 中文
Hematologists/Physicians Need to Be Aware of Pseudohypercalcemia in Monoclonal Gammopathy: Lessons from a Case Report. 血液病学家/医生需要警惕单克隆丙种球蛋白病的假性高钙血症：病例报告的启示。
IF 0.7
Case Reports in Hematology Pub Date : 2024-08-19 eCollection Date: 2024-01-01 DOI: 10.1155/2024/8844335
Svenja F B J Mennens, Ellen Van der Spek, Janneke Ruinemans-Koerts, Marcel M G J Van Borren
{"title":"Hematologists/Physicians Need to Be Aware of Pseudohypercalcemia in Monoclonal Gammopathy: Lessons from a Case Report.","authors":"Svenja F B J Mennens, Ellen Van der Spek, Janneke Ruinemans-Koerts, Marcel M G J Van Borren","doi":"10.1155/2024/8844335","DOIUrl":"10.1155/2024/8844335","url":null,"abstract":"<p><p>We present a patient at risk of misdiagnosis with multiple myeloma due to pseudohypercalcemia. Examinations showed monoclonal protein, 50% monoclonal plasma cells in bone marrow, and hypercalcemia but no osteolytic bone lesions. Follow-up tests revealed pseudohypercalcemia, with elevated total calcium, but normal ionized calcium: a discrepancy due to calcium binding to monoclonal paraprotein (confirmed by laboratory experiments). Accordingly, the patient was diagnosed with smouldering myeloma. After 900 days, the presence of bone lesions prompted the start of treatment for myeloma. Consequently, monoclonal paraprotein levels declined and pseudohypercalcemia dissolved. Hence, ionized calcium should be measured in monoclonal gammopathies to avoid misdiagnosis.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"8844335"},"PeriodicalIF":0.7,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel BCR::ABL1 Variant Detected with Multiple Testing Modalities. 通过多种检测方式检测到一种新型 BCR::ABL1 变异体。
IF 0.7
Case Reports in Hematology Pub Date : 2024-08-16 eCollection Date: 2024-01-01 DOI: 10.1155/2024/8486267
J Jean, M Sukhanova, D Dittmann, J Gao, L J Jennings
{"title":"A Novel <i>BCR::ABL1</i> Variant Detected with Multiple Testing Modalities.","authors":"J Jean, M Sukhanova, D Dittmann, J Gao, L J Jennings","doi":"10.1155/2024/8486267","DOIUrl":"10.1155/2024/8486267","url":null,"abstract":"<p><p>Chronic myeloid leukemia (CML) is associated with several breakpoint regions that result in different <i>BCR::ABL1</i> fusion transcripts. These include the major breakpoint region (M-BCR), minor breakpoint region (m-BCR), and mu breakpoint region (u-BCR) corresponding to p210, p190, and p230 fusion transcripts, respectively. This patient is a 38-year-old female with a new diagnosis of CML in chronic phase. A novel p210 fusion transcript splice variant was detected with qualitative reverse transcription PCR and capillary electrophoresis. Subsequent FISH study was performed, which revealed 86.5% positive for the <i>BCR::ABL1</i> fusion. Quantitative real-time polymerase chain reaction (PCR) showed a negative result for the p210 fusion transcript. The variant was further characterized by Sanger sequencing. This variant is in-frame and predicted to be functional. This case illustrates the need for a combination of different testing techniques to fully characterize the rare <i>BCR::ABL1</i> fusion transcripts.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"8486267"},"PeriodicalIF":0.7,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142056881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Leukaemia following Dengue Infection in Nepalese Patients: A Report of Two Cases. 尼泊尔患者感染登革热后出现急性白血病：两个病例的报告。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-28 eCollection Date: 2024-01-01 DOI: 10.1155/2024/8747138
Anushka Agrawal, Pratik Lamichhane, Rituraj Baral, Sabin Thapaliya
{"title":"Acute Leukaemia following Dengue Infection in Nepalese Patients: A Report of Two Cases.","authors":"Anushka Agrawal, Pratik Lamichhane, Rituraj Baral, Sabin Thapaliya","doi":"10.1155/2024/8747138","DOIUrl":"10.1155/2024/8747138","url":null,"abstract":"<p><p>Dengue is a mosquito-borne, acute febrile illness caused by dengue viruses. The association between hematological malignancies and dengue infection is obscure, and the literature on this occurrence is also limited. We report two cases of acute leukaemia following dengue infection in a recent outbreak in Nepal. Our case reports suggest a possible association of acute leukaemia with dengue infection. The relationship should be explored further with observational studies.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"8747138"},"PeriodicalIF":0.7,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complex Presentation of Multicentric Castleman Disease with Coexisting HIV, HHV-8, and Other Opportunistic Infections. 多中心卡斯特曼病与艾滋病病毒、HHV-8 和其他机会性感染并存的复杂表现。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-27 eCollection Date: 2024-01-01 DOI: 10.1155/2024/8817064
Yehya Tlaiss, Hadi Farhat, Firas Hasan, Rami Yazbek, Noura Shakaroun, Nizar Bitar
{"title":"Complex Presentation of Multicentric Castleman Disease with Coexisting HIV, HHV-8, and Other Opportunistic Infections.","authors":"Yehya Tlaiss, Hadi Farhat, Firas Hasan, Rami Yazbek, Noura Shakaroun, Nizar Bitar","doi":"10.1155/2024/8817064","DOIUrl":"10.1155/2024/8817064","url":null,"abstract":"<p><p>Castleman disease (CD) is a rare lymphoproliferative disorder characterized by benign lymph node enlargement. We present the case of a 43-year-old male with a complex medical history, including Crohn's disease treated with Adalimumab and later complicated with tuberculosis (TB) infection. Subsequently, in May 2021, he was diagnosed with human immunodeficiency virus (HIV) and started on antiretroviral therapy (efavirez, emricitabine, and tenofovir). Despite stropping adalimumab, anti-Tb, and antiviral therapy, he experienced persistent fever, neurological symptoms, and lymphadenopathy. Toxoplasmosis, Cytomegalovirus (CMV), and Human Herpesvirus-8 (HHV-8) were diagnosed and then treated. Furthermore, the patient displayed intermittent febrile episodes, pancytopenia, altered coagulation parameters, hypoalbuminemia, edema, and generalized abdominal pain, as well as radiological evidence of hepatosplenomegaly and pulmonary infiltrates. Left axillary lymph node biopsy (ALNB) was done and confirmed multicentric castleman disease (MCD). Moreover, the bone marrow aspirate showed plasmocytes. His treatment included chemotherapy with doxorubicin and rituximab while continuing his anti-Tb and antiretroviral therapy. This complex case highlights the diagnostic challenges of managing CD in the presence of multiple coexisting conditions, emphasizing the need for comprehensive evaluation in complex clinical presentations.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"8817064"},"PeriodicalIF":0.7,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11300082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141895185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
T-PLL Presenting with an Indolent Course. T-PLL 表现为惰性病程。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-24 eCollection Date: 2024-01-01 DOI: 10.1155/2024/7310135
Arsa Thammahong, Narittee Sukswai, Chantana Polprasert
{"title":"T-PLL Presenting with an Indolent Course.","authors":"Arsa Thammahong, Narittee Sukswai, Chantana Polprasert","doi":"10.1155/2024/7310135","DOIUrl":"10.1155/2024/7310135","url":null,"abstract":"<p><p>T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell leukemia which usually presents with aggressive behavior. We report an asymptomatic T-PLL patient diagnosed by clinical features, lymphocyte morphology, and flow cytometry. Incidentally, she was found to have lymphocytosis and lymphadenopathy. Flow cytometry from blood revealed an abnormally increased CD4+ T-cell population. T-cell receptor clonality assessment by next-generation sequencing revealed a dominant clone in the ß-chain constant region. No pathogenic mutations in 25 lymphoma-related genes were found. Due to her asymptomatic T-PLL disease, we observed her clinical situation and blood count every three months for at least one year.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"7310135"},"PeriodicalIF":0.7,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11300063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141895186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approach to Pregnancy Affected by Kell Alloimmunization. 受 Kell Alloimmunization 影响的妊娠方法。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-23 eCollection Date: 2024-01-01 DOI: 10.1155/2024/1929147
Serdar Aykut, Suleyman Cansun Demir, Ismaıl Cuneyt Evruke, Mete Sucu, Fatma Islek Uzay, Mesut Avan, Ozge Keles Bayer, Emre Yalcin
{"title":"Approach to Pregnancy Affected by Kell Alloimmunization.","authors":"Serdar Aykut, Suleyman Cansun Demir, Ismaıl Cuneyt Evruke, Mete Sucu, Fatma Islek Uzay, Mesut Avan, Ozge Keles Bayer, Emre Yalcin","doi":"10.1155/2024/1929147","DOIUrl":"10.1155/2024/1929147","url":null,"abstract":"<p><p>Hemolytic disease of the fetus and newborn (HDFN) is the development of anemia, hyperbilirubinemia, and finally hydrops fetalis in the fetus when antibodies to antigens on the surface of erythrocytes are transferred from the placenta to the fetus. The most common cause is D-HDFN. K (KEL1) from the Kell blood group system is the most potent immunogenic antigen after D among all blood group antigens. K-HDFN occurs in 0.1-0.3% of pregnant women. It accounts for 10% of cases of antibody-mediated severe fetal anemia. We present a successful management of Kell alloimmunization in a pregnant woman who had 3 times pregnancy loss with hydrops fetalis due to K-HDFN and who was proven to have K-HDFN in the postnatal period in her last pregnancy.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"1929147"},"PeriodicalIF":0.7,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EBV Positive Diffuse Large B Cell Lymphoma with Negative Pan-B Cell Markers, Case Report, and Literature Review. EBV阳性弥漫大B细胞淋巴瘤，泛B细胞标志物阴性，病例报告和文献综述。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-18 eCollection Date: 2024-01-01 DOI: 10.1155/2024/4803071
Janna Shold, Lea Jukic, Daniel Farrell, Wei Cui, Da Zhang
{"title":"EBV Positive Diffuse Large B Cell Lymphoma with Negative Pan-B Cell Markers, Case Report, and Literature Review.","authors":"Janna Shold, Lea Jukic, Daniel Farrell, Wei Cui, Da Zhang","doi":"10.1155/2024/4803071","DOIUrl":"10.1155/2024/4803071","url":null,"abstract":"<p><p>Most B cell lymphomas are positive for one or more B cell markers including CD19, CD20, CD79a, or PAX5. However, rare cases of mature B cell lymphoma not expressing any B cell markers have been characterized and recognized as distinct diagnostic entities by current classification guidelines, including plasmablastic lymphoma, primary effusion lymphoma, and ALK-positive large B cell lymphoma. We present a case of pan-B cell marker negative, EBV positive diffuse large B cell lymphoma that is positive for OCT2, BOB1, and clonal immunoglobulin gene rearrangement that does not meet diagnostic criteria for any B cell lymphoma by current 4<sup>th</sup> and 5<sup>th</sup> Ed beta version WHO Hematolymphoid Tumors classification. In challenging cases like the one presented, utilizing OCT2 and BOB1 immunohistochemical stains can assist in determining B cell lineage. The WHO tumor classification system should consider adding OCT2 and BOB1 as alternative B cell lineage markers into their corresponding categories.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"4803071"},"PeriodicalIF":0.7,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11272396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk. 第一代和第二代布鲁顿酪氨酸激酶抑制剂患者的心包炎和心脏填塞：未被充分认识的风险。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-09 eCollection Date: 2024-01-01 DOI: 10.1155/2024/2312182
Thomas Erblich, Charlotte Manisty, John Gribben
{"title":"Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk.","authors":"Thomas Erblich, Charlotte Manisty, John Gribben","doi":"10.1155/2024/2312182","DOIUrl":"10.1155/2024/2312182","url":null,"abstract":"<p><strong>Introduction: </strong>The introduction of Bruton's tyrosine kinase (BTK) inhibitors significantly improved the management of chronic lymphocytic leukemia (CLL). However, BTK carry the risk of cardiotoxicity, which is not only limited to atrial fibrillation. <i>Case Reports</i>. We report three cases of patients on BTK inhibitors who developed acute pericarditis and cardiac tamponade. We report the first patient who developed this complication on treatment with zanubrutinib. This patient's treatment was changed to zanubrutinib due to atrial fibrillation. Shortly after cardioversion, he developed cardiac tamponade and shock. He underwent pericardiocentesis, received treatment for acute pericarditis with steroids and colchicine, and made a full recovery. We also report two further cases, both involving patients treated with ibrutinib. These patients also developed acute pericarditis and cardiac tamponade and required pericardiocentesis. All three patients discontinued BTK therapy following the events.</p><p><strong>Conclusions: </strong>These three cases highlight the rare but potentially life-threatening risk of cardiac tamponade which can occur even with newer generations of BTK inhibitors. Haemato-oncologists should remain vigilant in patients who report dyspnea or who show sinus tachycardia on routine electrocardiography. Even in the absence of classical clinical signs of tamponade, patients require urgent evaluation with echocardiography and potentially emergency pericardiocentesis.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"2312182"},"PeriodicalIF":0.7,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11251797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141628066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hodgkin Lymphoma Presenting as Cardiac Tamponade in a Young Female. 一名年轻女性在霍奇金淋巴瘤中表现为心脏填塞。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-08 eCollection Date: 2024-01-01 DOI: 10.1155/2024/5597263
Georgia Kaiafa, Stylianos Daios, Stavroula Bountola, Triantafyllia Koletsa, Michail Makris, Charikleia Chatzikosma, Antonia Loukousia, Vasileios Perifanis, Antonios Ziakas, Christos Savopoulos
{"title":"Hodgkin Lymphoma Presenting as Cardiac Tamponade in a Young Female.","authors":"Georgia Kaiafa, Stylianos Daios, Stavroula Bountola, Triantafyllia Koletsa, Michail Makris, Charikleia Chatzikosma, Antonia Loukousia, Vasileios Perifanis, Antonios Ziakas, Christos Savopoulos","doi":"10.1155/2024/5597263","DOIUrl":"10.1155/2024/5597263","url":null,"abstract":"<p><p>Hodgkin lymphoma (HL) is an uncommon malignancy that is characterized by Hodgkin or Reed-Sternberg cells. Cardiac implications of HL remain one of the least investigated subjects. There are few case reports in the literature of cardiac tamponade in HL patients. We describe a case of a 21-year-old female patient who presented with cardiac tamponade as an initial presentation of HL. Any pericardial effusion significant for tamponade requires immediate drainage and fluid analysis for thorough investigation. Prompt identification and timely intervention are crucial in effectively addressing these complex situations. Therefore, clinicians should maintain heightened awareness in such cases.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"5597263"},"PeriodicalIF":0.7,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141628065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De Novo Variant in the RPL27 Gene in a Second Infant with Diamond-Blackfan Anemia. 第二例菱形黑方贫血症婴儿的 RPL27 基因新变异。
IF 0.7
Case Reports in Hematology Pub Date : 2024-07-03 eCollection Date: 2024-01-01 DOI: 10.1155/2024/6626388
Joshua Glass, Julia Weston, Amy Feldman Lewanda, Suvankar Majumdar
{"title":"<i>De Novo</i> Variant in the <i>RPL27</i> Gene in a Second Infant with Diamond-Blackfan Anemia.","authors":"Joshua Glass, Julia Weston, Amy Feldman Lewanda, Suvankar Majumdar","doi":"10.1155/2024/6626388","DOIUrl":"10.1155/2024/6626388","url":null,"abstract":"<p><p>We describe a 10-month-old female with Diamond-Blackfan anemia (DBA) who presented with macrocytic anemia and reticulocytopenia. Whole exome sequencing revealed a <i>de novo</i> intronic variant in <i>RPL27</i> (NM_000988.3:c.-2-1G > A p.?) previously reported in one individual with DBA. The existing literature suggests the <i>RPL27</i> gene encodes for a ribosomal protein involved in pre-rRNA processing and erythropoiesis. Further research is needed to assess the functional significance of this variant and its implications for genetic testing and therapeutic strategies. This case expands the clinical spectrum of <i>RPL27</i>-associated DBA and highlights the importance of reclassifying this gene to likely pathogenic.</p>","PeriodicalId":46307,"journal":{"name":"Case Reports in Hematology","volume":"2024 ","pages":"6626388"},"PeriodicalIF":0.7,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信